Bal Pharma share price is Up ▲ 16.11% on 22-Aug-2024

Bal Pharma share price is Up ▲ 16.11% on 22-Aug-2024. | 1.82m shares traded.
Its CMP is Rs 137.68 and MCap is approx. : 219 Crores.
The stock is up ▲ 22.5% in 7 days,
up ▲ 22.2% in 1 month
and up ▲ 14.6% in 2 months.
Please click image for Latest Daily data.
Bal Pharma results June 2024 (Standalone_YoY) Bal Pharma revenue elevated to 73 crores up 4% in June 2024 quarter, compared with 70 crores in June 2023. Bal Pharma Net profit is 2 crores up 100% in June 2024 quarter, compared with 1 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
* Data updated everyday at 7pm. Only Data. Not Buy or Sell advice.

Click Image for Data | Scroll down for Comments

About Bal Pharma :

Founded: 1987
Headquarters: India
Number of employees: 869 (2023)
Subsidiaries: Golden Drugs Private Limited…

Bal Pharma Limited is an Indian pharmaceutical company that specializes in prescription drugs, generic and over-the-counter products, intravenous infusions, and bulk actives. The company was founded in 1987 and is headquartered in Bangalore, Karnataka. Bal Pharma has 25 years of experience and aims to provide safe, effective, high quality, and affordable products. The company’s products include tablets, capsules, syrups, suspensions, IV infusions, creams, and ointments. Bal Pharma also offers a range of natural medicine, including ANARSHA, ASHWAMED, AYURFINE, AYURFINE FORTE, AYURSULIN, IMMUWIN, LIPIVED, MENOLEAP CAPSULES, MENOLEAP SYRUP, PROLIFE, and BALPRO SYRUP.

Bal Pharma’s API and FDF are produced at world class manufacturing facilities. APIs are exported to Europe, Far East, Latin America, Africa, Middle East, and other world markets. FDF are exported to semi-regulated and non-regulated markets.
—————————————————-
* About company information is from various sources on the internet ( March 2024 ).
Please verify the official website of company for the latest updated information.
—————————————————-

Please visit